FDA requires generic ADHD drug companies to prove their effectiveness

by Robert Preidt - Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the U.S. Food and Drug Administration said Thursday. The agency analyzed available data and conducted laboratory tests on the two generic versions of Concerta (methylphenidate hydrochloride extended-release tablets) made by Mallinckrodt Pharmaceuticals […]